DrugDashboards

Atropine Sulfate

Atropine Sulfate · ATROPINE SULFATE .1 mg/mL · Injection · Intravenous · HF Acquisition Co LLC, DBA HealthFirst

NDC 51662-1527-03 · 10 POUCH in 1 CASE / 1 CARTON in 1 POUCH / 1 SYRINGE in 1 CARTON / 10 mL in 1 SYRINGE · ANDA · View full market →

The short version

8 companies supply this market — a reasonable cushion if one runs into trouble. It is in shortage right now — FDA lists the reason as “discontinuation of the manufacture of the drug”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Medicare Part B pays (ASP+6%)$0.1120per billing unit (0.01 MG)HCPCS J0461 · Jul 1, 2026
  • Part D plans paid (avg)$4.08per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Medicare Part B (ASP)

Payment limit per 0.01 MG
$0.112
HCPCS J0461 · Jul 1, 2026 quarter · typically ASP + 6%

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $47.18 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA212461
TE code
AP
Approval date
Oct 5, 2020
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10)Dec 20, 2023
    month 33 of a typical 20 for injectable shortages · model puts 22% odds it resolves within 6 months
  • In shortage now — Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03)Jan 1, 2020
    Discontinuation of the manufacture of the drug
    month 81 — 4× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90)Jan 1, 2020
    Discontinuation of the manufacture of the drug
    month 81 — 4× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Atropine Sulfate, Injection, .1 mg/1 mL (NDC 76329-3340-1)Jan 1, 2020
    month 81 — 4× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Atropine Sulfate, Injection, 0.1 mg/1 mL (NDC 16729-484-45)Jan 1, 2020
    month 81 — 4× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Atropine Sulfate (Injection)

LabelerStrengthFirst seenLast seen
Hikma Pharmaceuticals USA Inc.ATROPINE SULFATE .4 mg/mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCATROPINE SULFATE .4 mg/mLJul 15, 2026Sep 3, 2026
A-S Medication SolutionsATROPINE SULFATE .1 mg/mLJul 15, 2026Sep 2, 2026
Accord Healthcare, Inc.,ATROPINE SULFATE .05 mg/mLJul 15, 2026Sep 2, 2026
Accord Healthcare, Inc.,ATROPINE SULFATE .1 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstATROPINE SULFATE .1 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.ATROPINE SULFATE 1 mg/mLJul 15, 2026Sep 2, 2026
International Medication Systems, LimitedATROPINE SULFATE .1 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionATROPINE SULFATE .1 mg/mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.ATROPINE SULFATE .1 mg/mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.ATROPINE SULFATE .4 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstATROPINE SULFATE .4 mg/mLJul 15, 2026Aug 31, 2026
Medical Purchasing Solutions, LLCATROPINE SULFATE .1 mg/mLJul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Atropine Sulfate — NDC 51662-1527-03," retrieved September 3, 2026, https://drugdashboards.com/drug/51662152703.

Free to cite with attribution — see how the data is put together.